Substance Use Disorder

The Model Addressing Drug Diversion in Healthcare Settings Act (1) requires healthcare entities to establish policies and procedures for the prevention and detection of drug diversion by healthcare professionals and to ensure that treatment and recovery support services are offered to eligible healthcare professionals; (2) requires certain individuals and entities to report healthcare professionals suspected of misusing drugs and/or alcohol, diverting drugs for personal use, having an untreated substance use disorder, or practicing while impaired and to establish penalties for failure to make such reports; (3) requires boards, as defined in this Act, to establish or participate in an alternative to discipline program for eligible healthcare professionals; (4) establishes legal protections for individuals who make reports as required by this Act; (5) provides immunity from civil and criminal liability for specified individuals and entities for actions taken pursuant to this Act; (6) establishes penalties for healthcare entities that fail to take corrective action after discovering diversion by a healthcare professional; (7) establishes program reporting and audit requirements; (8) establishes technology grants for healthcare entities to be used for the prevention and detection of drug diversion; and (9) establishes funding provisions for alternative to discipline programs....

Ryther, a nonprofit mental health service provider for children, teens, and young adults in Seattle, Washington, provides therapeutic services to youth struggling with mental and behavioral health issues, including substance use disorder (SUD). As part of its menu of services for SUD treatment, Ryther offers medication for addiction treatment (MAT) for those aged 12 to 25 who have opioid use disorder (OUD), making the program unique in focusing on young people. Ryther’s MAT program provides holistic treatment that addresses the physical, mental, emotional, and social challenges faced by children and young adults with SUD. Many of the participants in Ryther’s MAT program are homeless or experiencing housing instability, and the program is designed to provide these individuals with low barrier resources and support....

In 2022, Frank Taylor, co-owner of Taylor Made Farm, a farm in Lexington, Kentucky for elite racehorses, pioneered the idea of opening the farm to men in need of substance use recovery to start their journey to long-term recovery by learning to take care of the farm’s million-dollar horses. He partnered with Christian Countzler, an Army veteran, to open Stable Recovery, a substance use disorder recovery program that combines peer recovery and 12-step program participation with horsemanship. ...

In collaboration with the University of Rhode Island College of Pharmacy, the Legislative Analysis and Public Policy Association (LAPPA) recently released "Pharmacists and Buprenorphine: Analysis of State Laws and Regulations." Funded by the Foundation for Opioid Response Efforts (FORE) Foundation, this project, named Pharmacy Bridge, focused on a demonstration of the real-world application and outcomes of two innovative models of pharmacy-based, low-barrier buprenorphine induction and maintenance services: (1) collaborative care through a collaborative practice agreement (CPA); and (2) independent pharmacist prescribing of buprenorphine. The report contains state-by-state descriptions and analyses of relevant statutes and regulations as well as a detailed summary of overall findings....

Beginning in 2020, the Legislative Analysis and Public Policy Association (LAPPA) undertook an ongoing research project to identify both currently-in-force statutes and recently proposed legislation related to overdose fatality review (OFR), throughout all 50 states, the District of Columbia, and U.S. territories, titled “Overdose Fatality Review Boards: State Laws” (previously updated February 2021). This document represents the latest iteration of that project, with information updated through December 2023. As of that date, 18 states have laws authorizing the establishment of state-level and/or locality-level OFRs....

The Office of National Drug Control Policy (ONDCP) is an agency of the Executive Office of the President and is charged with leading and coordinating “the nation’s drug policy so that it improves the health and lives of the American people." This document provides statutory, regulatory. and legislative information about the nineteen states that have followed ONDCP’s example and created either a state-level office of drug control policy or an advisory commission separate from the state agency charged with oversight of controlled substances that is dedicated to addressing alcohol and drug abuse issues in the state....

In 2024, the Office of National Drug Control Policy (ONDCP) convened an interagency working group (IWG) comprised of 30 federal agencies to identify federal recovery research gaps and opportunities on recovery from substance use disorder (SUD). This article outlines the process undertaken to identify these research opportunities and describes four core research topic areas and three cross-cutting themes and provides the rationale for their selection. It also identifies potential pathways for recovery research, including evaluation and data collection activities, and discusses challenges and potential opportunities for recovery research....